Merja Soilu-Hänninen
MD, PhD
Turku University Hospital, Division of Clinical Neurosciences mersoi@utu.fi |
Clinical neurology; neuroimmunology; multiple sclerosis risk factors, prognostic factors and treatment
MD, University of Turku 1988
PhD, University of Turku, Department of Virology, Immunobiology of central nervous system virus infections 1996
Postdoctoral Fellow, Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia 1997-1999
Specialist Degree in Neurology 2001
Adjuct Professor of Clinical Neurology 2008
Inverstigator in several clinical MS trials
Chair of the Finnish MS registry 2016-
General Neurology Section Head, Turku University Hospital, Division of Clinical Neurosciences 2017-
Multiple sclerosis risk factors, prognostic factors and epidemiology.
Imaging of brain atrophy in multiple sclerosis.
Course of medical pedagogics 2011-2012
Supervisor of several PhD student
- Epstein–barr virus and multiple sclerosis risk in the finnish maternity cohort (2019)
- Annals of Neurology
- Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004–2014: A retrospective national registry study (2019)
- Journal of the Neurological Sciences
- MS-tauti ja kognitiivinen toimintakyky (2019)
- Duodecim
- Multiple sclerosis epidemiology in Finland: regional differences and high incidence (2019)
- Acta Neurologica Scandinavica
- Multiple sclerosis in Finland 2018—Data from the national register (2019)
- Acta Neurologica Scandinavica
- Multiple sclerosis registries in Europe - An updated mapping survey (2019)
- Multiple Sclerosis and Related Disorders
- Progressive dopaminergic defect in a patient with primary progressive multiple sclerosis (2019)
- Multiple Sclerosis and Related Disorders
- Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study (2019)
- Journal of Neurology
- Risk of cancer among Finnish multiple sclerosis patients (2019)
- Multiple Sclerosis and Related Disorders
- Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis (2019)
- Frontiers in Neurology



